Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular neridronate in osteoporosis associated with Parkinson's disease
2010-018904-94Phase 3Terminated
- Sponsor
- Fondazione Salvatore Maugeri
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of neridronic acid in osteoporosis, sponsored by Fondazione Salvatore Maugeri. Primary endpoint: Improvement in lumbar bone mineral density. Started Mar 2012; status: terminated.
02
Drugs
neridronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2010-018904-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018904-94.